GBA1 and arthritic joint disease: Yang [40] showed that glucocerebrosidase (GBA) administration improved arthritis in mice, and in parallel, circulating inflammatory mediators, including IL-1β, IL-6, IL-18 and matrix metalloproteinase (MMP)-1 levels were also improved.